- Industry: Healthcare
Though the CMS announcement seems to be universally welcomed, its immediate impact will be limited, notes Nathan Ray, a senior manager with consulting firm of West Monroe Partners. With its focus on a short list of conditions and being tested in only seven states, the initiative will impact only a subset of providers initially, he says, but the outcomes will have significant influence on things to come for more than the initial model population and not limited to Medicare Advantage.
Of particular note is the benefit designation of "high value" services, providers, and disease management programs, which drives the extension of resources to participants under reduced cost sharing benefit designs, he notes.
To read the full article as it ran in HealthLeaders, click here.